Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
2022-02-15 Purchase | 2022-02-17 4:00 pm | Kintara Therapeutics Inc. | KTRA | Hoffman Robert E. President and CEO | 55,000 | $0.469 | $25,795 | 55,000 (Direct) | View |
2021-12-08 Purchase | 2021-12-09 4:09 pm | Kintara Therapeutics Inc. | KTRA | Praill Anthony Scott Chief Financial Officer | 28,700 | $0.677 | $19,430 | 37,186 (Direct) | View |
2021-12-06 Purchase | 2021-12-08 4:09 pm | Kintara Therapeutics Inc. | KTRA | Zarrabian Saiid Head of Strategic Partnerships | 50,000 | $0.62633 | $31,316 | 56,090 (Indirect Direct) | View |
2021-11-22 Purchase | 2021-11-24 4:06 pm | Kintara Therapeutics Inc. | KTRA | Johnson Laura L. Director | 3,000 | $0.7423 | $2,227 | 3,000 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2024-11-12 Option Award | 2024-11-14 4:48 pm | N/A 2034-11-12 | TuHURA Biosciences Inc. | HURA | Bianco James A. Chief Executive Officer | 1,065,990 | $0 | 1,065,990 (Direct) | View |
2024-11-12 Option Award | 2024-11-14 4:46 pm | N/A 2034-11-12 | TuHURA Biosciences Inc. | HURA | Dearborn Dan Chief Financial Officer | 489,848 | $0 | 489,848 (Direct) | View |
2024-10-18 Option Award | 2024-10-22 9:12 pm | N/A 2034-01-19 | Kintara Therapeutics Inc. | KTRA | Yamashita Dennis Chief Scientific Officer | 196,790 | $0 | 196,790 (Direct) | View |
Ownership | 2024-10-22 8:50 pm | N/A N/A | Kintara Therapeutics Inc. | KTRA | Patel Vijay 10% Owner | 0 | $0 | 12,364,430 (Indirect) | View |
2024-10-18 Option Award | 2024-10-22 8:47 pm | 2024-10-18 2030-02-06 | Kintara Therapeutics Inc. | KTRA | Ng George K Director | 62,886 | $0 | 62,886 (Direct) | View |
Ownership | 2024-10-22 8:44 pm | N/A N/A | Kintara Therapeutics Inc. | KTRA | Ng George K Director | 0 | $0 | 0 (Direct) | View |
2024-10-18 Option Award | 2024-10-22 8:41 pm | 2024-10-18 2033-01-16 | Kintara Therapeutics Inc. | KTRA | List Alan Director | 27,106 | $0 | 27,106 (Direct) | View |
Ownership | 2024-10-22 8:38 pm | N/A N/A | Kintara Therapeutics Inc. | KTRA | List Alan Director | 0 | $0 | 0 (Direct) | View |
2024-10-18 Option Award | 2024-10-22 8:36 pm | 2024-10-18 2033-01-16 | Kintara Therapeutics Inc. | KTRA | MANUSO JAMES S J Director | 27,106 | $0 | 27,106 (Direct) | View |
Ownership | 2024-10-22 8:33 pm | N/A N/A | Kintara Therapeutics Inc. | KTRA | MANUSO JAMES S J Director | 0 | $0 | 0 (Direct) | View |
Ownership | 2024-10-22 8:13 pm | N/A N/A | Kintara Therapeutics Inc. | KTRA | Yamashita Dennis Chief Scientific Officer | 0 | $0 | 0 (Direct) | View |
2024-10-18 Option Award | 2024-10-22 8:10 pm | 2024-10-18 2031-07-01 | Kintara Therapeutics Inc. | KTRA | Bianco James A. Chief Executive Officer | 2,943,947 | $0 | 2,943,947 (Direct) | View |
Ownership | 2024-10-22 8:07 pm | N/A N/A | Kintara Therapeutics Inc. | KTRA | Bianco James A. Chief Executive Officer | 0 | $0 | 0 (Direct) | View |
2024-10-18 Option Award | 2024-10-22 8:01 pm | 2024-10-18 2026-01-17 | Kintara Therapeutics Inc. | KTRA | Dearborn Dan Chief Financial Officer | 417,401 | $0 | 417,401 (Direct) | View |
Ownership | 2024-10-22 7:56 pm | N/A N/A | Kintara Therapeutics Inc. | KTRA | Dearborn Dan Chief Financial Officer | 0 | $0 | 0 (Direct) | View |
2023-08-30 Option Award | 2023-09-01 6:00 pm | N/A 2033-08-30 | Kintara Therapeutics Inc. | KTRA | Johnson Laura L. Director | 8,500 | $0 | 8,500 (Direct) | View |
2023-08-30 Option Award | 2023-09-01 6:00 pm | N/A 2033-08-30 | Kintara Therapeutics Inc. | KTRA | FAVORITO TAMARA A Director | 8,500 | $0 | 8,500 (Direct) | View |
2023-08-30 Option Award | 2023-09-01 6:00 pm | N/A 2033-08-30 | Kintara Therapeutics Inc. | KTRA | Hoffman Robert E. President, CEO and Interim CFO | 23,142 | $0 | 23,142 (Direct) | View |
2023-08-30 Option Award | 2023-09-01 6:00 pm | N/A 2033-08-30 | Kintara Therapeutics Inc. | KTRA | TOTH ROBERT JOSEPH JR Director | 8,500 | $0 | 8,500 (Direct) | View |
2023-08-30 Option Award | 2023-09-01 6:00 pm | N/A 2033-08-30 | Kintara Therapeutics Inc. | KTRA | Brown Dennis M Chief Scientific Officer | 10,175 | $0 | 10,175 (Direct) | View |
2023-06-01 Option Award | 2023-06-02 4:05 pm | N/A N/A | Kintara Therapeutics Inc. | KTRA | Hoffman Robert E. President, CEO, and CFO | 59,800 | $0 | 68,902 (Direct) | View |
2023-01-05 Acquisition | 2023-01-06 7:26 pm | N/A N/A | Kintara Therapeutics Inc. | KTRA | Brown Dennis M Chief Scientific Officer | 363 | $0 | 6,377 (Direct) | View |
2022-08-01 Option Award | 2022-08-03 4:30 pm | N/A 2022-08-02 | Kintara Therapeutics Inc. | KTRA | Praill Anthony Scott Chief Financial Officer | 960,347 | $0 | 997,533 (Direct) | View |
2022-08-01 Option Award | 2022-08-03 4:30 pm | N/A 2022-08-02 | Kintara Therapeutics Inc. | KTRA | Brown Dennis M Chief Scientific Officer | 960,347 | $0 | 1,020,915 (Direct) | View |
2022-08-01 Option Award | 2022-08-03 4:30 pm | N/A 2022-08-02 | Kintara Therapeutics Inc. | KTRA | Hoffman Robert E. President and CEO | 1,600,779 | $0 | 1,655,779 (Direct) | View |
2022-07-01 Option Award | 2022-07-05 4:05 pm | N/A 2032-07-01 | Kintara Therapeutics Inc. | KTRA | Johnson Laura L. Director | 100,000 | $0 | 100,000 (Direct) | View |
2022-07-01 Option Award | 2022-07-05 4:05 pm | N/A 2032-07-01 | Kintara Therapeutics Inc. | KTRA | TOTH ROBERT JOSEPH JR Director | 100,000 | $0 | 100,000 (Direct) | View |
2022-07-01 Option Award | 2022-07-05 4:05 pm | N/A 2032-07-01 | Kintara Therapeutics Inc. | KTRA | SEYMOUR TAMARA A Director | 100,000 | $0 | 100,000 (Direct) | View |
2021-11-08 Option Award | 2021-11-10 4:18 pm | N/A 2031-11-08 | Kintara Therapeutics Inc. | KTRA | HOFFMAN ROBERT President and CEO | 3,519,170 | $0 | 3,519,170 (Direct) | View |
2021-09-22 Option Award | 2021-09-22 8:43 pm | N/A 2031-09-22 | Kintara Therapeutics Inc. | KTRA | Murphy Keith Director | 100,000 | $0 | 100,000 (Direct) | View |
2021-09-22 Option Award | 2021-09-22 8:40 pm | N/A 2031-09-22 | Kintara Therapeutics Inc. | KTRA | TOTH ROBERT JOSEPH JR Director | 100,000 | $0 | 100,000 (Direct) | View |
2021-09-22 Option Award | 2021-09-22 8:37 pm | N/A 2031-09-22 | Kintara Therapeutics Inc. | KTRA | SEYMOUR TAMARA A Director | 35,000 | $0 | 35,000 (Direct) | View |
2021-09-22 Option Award | 2021-09-22 8:35 pm | N/A 2031-09-22 | Kintara Therapeutics Inc. | KTRA | HOFFMAN ROBERT Director | 100,000 | $0 | 100,000 (Direct) | View |
2021-09-22 Option Award | 2021-09-22 8:31 pm | N/A 2031-09-22 | Kintara Therapeutics Inc. | KTRA | Johnson Laura L. Director | 100,000 | $0 | 100,000 (Direct) | View |
2021-04-29 Option Award | 2021-05-03 4:34 pm | N/A 2031-04-29 | Kintara Therapeutics Inc. | KTRA | SEYMOUR TAMARA A Director | 75,000 | $0 | 75,000 (Direct) | View |